IGC Pharma (IGC) Net Cash Flow (2010 - 2025)
IGC Pharma (IGC) posted quarterly Net Cash Flow of $646000.0 for Q3 2025, up 341.95% year-over-year from $146171.2 in Q3 2024, and up 2591.67% quarter-over-quarter from $24000.0 in Q2 2025.
IGC Pharma (IGC) Net Cash Flow (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Net Cash Flow for 16 consecutive years, with $646000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Net Cash Flow rose 341.95% year-over-year to $646000.0; the TTM figure through Mar 2026 stood at $670000.0 (up 185.24% YoY), while the FY2026 annual figure was -$683000.0, up 13.1% from the prior year.
- Net Cash Flow rose to $646000.0 in Q3 2025 per IGC's latest filing, from $24000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $13.6 million in Q1 2021 and bottomed at -$2.5 million in Q4 2021.
- Historically, Net Cash Flow has averaged $12052.6 across 5 years, with a median of -$1.1 million in 2024.
- On a YoY basis, Net Cash Flow climbed as much as 583.14% in 2021 and fell as far as 1194.24% in 2021.
- IGC Pharma's Net Cash Flow stood at -$2.5 million in 2021, then surged by 32.65% to -$1.7 million in 2022, then advanced by 0.96% to -$1.6 million in 2023, then surged by 34.75% to -$1.1 million in 2024, then jumped by 160.04% to $646000.0 in 2025.
- Business Quant data shows IGC's Net Cash Flow at $646000.0 in Q3 2025, $24000.0 in Q2 2025, and -$67000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 646,000.00 |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -267,000.00 |
| Sep 30, 2024 | -267,000.00 |
| Jun 30, 2024 | 624,000.00 |
| Jun 30, 2024 | 624,000.00 |
| Mar 31, 2024 | -182,000.00 |
| Mar 31, 2024 | -182,000.00 |
| Dec 31, 2023 | -1.65 Mn |
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | -1.47 Mn |
| Jun 30, 2023 | -1.47 Mn |